“The gene SRD5A2 may be tissue specific and not centralised to one single gene that controls expression.” This would explain the vast array in symptoms between PFS patients. When Melcangi checked the cerebral spinal fluid in PFS patients more than half 56.3% showed methylation of the SRD5A2 against controls this is a substantial difference with the unmethylated controls showing higher pregnenolone, dihydrotestosterone and dihydroprogesterone production compared to PFS patients with the methylated SRD5A2 gene. This to me shows a very clear connection that methylation of this gene has an impact on production of key hormones and may be the central cause of Post Finasteride Syndrome. The reason why other PFS patients didn’t show methylation of the SRD5A2 gene in the CSF is simply because Post Finasteride Syndrome is a site specific disease as SRD5A2 is locally expressed in key tissues and not coming from one single gene. It would have been interesting to compare the differences in symptoms between these patients with PFS and methylation in the CSF.
The first sites I believe to get hit by Post Finasteride Syndrome is the prostate, penile tissue and brain as these sites contain the highest concentration of DHT. The genetic predisposition for me will always come down to how much locally acting DHT was being produced in tissues the higher the amount the more predisposed you become. I’m also of the belief that individuals who have been exposed to some anti androgen in the past makes them more susceptible to PFS whether this was taking an antidepressant, shampoo containing anti androgen compounds or some other medication or supplement making tissues more primed for PFS. I’m also of the belief that the reason why people may see an improvement over time is that the methylation of these tissues may decrease as we age but obviously isn’t the case for everyone.
If professor Melcangi had of taken a skin biopsy of the penile tissue in patients with PFS who complained of sexual dysfunction I’m sure that he’d find 80% plus methylation of the SRD5A2 gene.